These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38289240)

  • 1. Xylazine Use Among People Who Inject Drugs, Philadelphia 2022.
    Tan M; Nassau T; Kuncio D; Higgins D; Teixeira da Silva D; Tomlinson D; Brady KA
    J Addict Med; 2024 Mar-Apr 01; 18(2):194-200. PubMed ID: 38289240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis.
    Friedman J; Montero F; Bourgois P; Wahbi R; Dye D; Goodman-Meza D; Shover C
    Drug Alcohol Depend; 2022 Apr; 233():109380. PubMed ID: 35247724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing presence of xylazine in heroin and/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019.
    Johnson J; Pizzicato L; Johnson C; Viner K
    Inj Prev; 2021 Aug; 27(4):395-398. PubMed ID: 33536231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current attitudes toward drug checking services and a comparison of expected with actual drugs present in street drug samples collected from opioid users.
    Swartz JA; Lieberman M; Jimenez AD; Mackesy-Amiti ME; Whitehead HD; Hayes KL; Taylor L; Prete E
    Harm Reduct J; 2023 Jul; 20(1):87. PubMed ID: 37420196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data.
    Bradford W; Figgatt M; Scott KS; Marshall S; Eaton EF; Dye DW
    Harm Reduct J; 2024 Feb; 21(1):46. PubMed ID: 38378660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Analysis of Drugs: A Pilot Surveillance System To Detect Changes in the Illicit Drug Supply To Guide Timely Harm Reduction Responses - Eight Syringe Services Programs, Maryland, November 2021-August 2022.
    Russell E; Sisco E; Thomson A; Lopes J; Rybak M; Burnett M; Heilman D; Appley MG; Gladden RM
    MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(17):458-462. PubMed ID: 37104171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the Intersection of Behavioral Risk and Social Determinants of Health and the Impact on an Outbreak of Human Immunodeficiency Virus Among Persons Who Inject Drugs in Philadelphia.
    Kim MM; Conyngham SC; Smith C; Higgins D; Nassau T; Terrell C; Brady KA
    J Infect Dis; 2020 Sep; 222(Suppl 5):S250-S258. PubMed ID: 32877552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reported xylazine exposure highly associated with overdose outcomes in a rapid community assessment among people who inject drugs in Baltimore.
    German D; Genberg B; Sugarman O; Saloner B; Sawyer A; Glick JL; Gribbin M; Flynn C
    Harm Reduct J; 2024 Jan; 21(1):18. PubMed ID: 38254198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations from people who use drugs in Philadelphia, PA about structuring point-of-care drug checking.
    Reed MK; Borne E; Esteves Camacho T; Kelly M; Rising KL
    Harm Reduct J; 2024 Jan; 21(1):26. PubMed ID: 38287409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl overdose concerns among people who inject drugs: The role of sex, racial minority status, and overdose prevention efforts.
    Jones AA; Schneider KE; Mahlobo CT; Maggs JL; Dayton L; Tobin KE; Latkin CA
    Psychol Addict Behav; 2023 Mar; 37(2):191-198. PubMed ID: 35511529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid overdoses involving xylazine in emergency department patients: a multicenter study.
    Love JS; Levine M; Aldy K; Brent J; Krotulski AJ; Logan BK; Vargas-Torres C; Walton SE; Amaducci A; Calello D; Hendrickson R; Hughes A; Kurt A; Judge B; Pizon A; Schwarz E; Shulman J; Wiegan T; Wax P; Manini AF
    Clin Toxicol (Phila); 2023 Mar; 61(3):173-180. PubMed ID: 37014353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of recent overdose among people who inject drugs in the San Diego/Tijuana border region.
    Bailey K; Abramovitz D; Patterson TL; Harvey-Vera AY; Vera CF; Rangel MG; Friedman J; Davidson P; Bourgois P; Strathdee SA
    Drug Alcohol Depend; 2022 Nov; 240():109644. PubMed ID: 36179507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips.
    Reed MK; Imperato NS; Bowles JM; Salcedo VJ; Guth A; Rising KL
    Drug Alcohol Depend Rep; 2022 Sep; 4():100074. PubMed ID: 36846574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review.
    Zhu DT
    Harm Reduct J; 2023 Sep; 20(1):131. PubMed ID: 37700329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaps in naloxone ownership among people who inject drugs during the fentanyl wave of the opioid overdose epidemic in New York City, 2018.
    Rivera AV; Nolan ML; Paone D; Carrillo SA; Braunstein SL
    Subst Abus; 2022; 43(1):1172-1179. PubMed ID: 35617642
    [No Abstract]   [Full Text] [Related]  

  • 16. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
    Harris RE; Richardson J; Frasso R; Anderson ED
    Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD.
    Park JN; Weir BW; Allen ST; Chaulk P; Sherman SG
    Harm Reduct J; 2018 Jul; 15(1):34. PubMed ID: 29976195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs.
    Blackburn NA; Lancaster KE; Ha TV; Latkin CA; Miller WC; Frangakis C; Chu VA; Sripaipan T; Quan VM; Minh NL; Vu PT; Go VF
    Harm Reduct J; 2017 Sep; 14(1):62. PubMed ID: 28882143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first drug-related death associated with xylazine use in the UK and Europe.
    Rock KL; Lawson AJ; Duffy J; Mellor A; Treble R; Copeland CS
    J Forensic Leg Med; 2023 Jul; 97():102542. PubMed ID: 37236142
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.